Trial Profile
A phase II trial of MER-3001 for Type-1 diabetes mellitus
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 19 Jan 2018
Price :
$35
*
At a glance
- Drugs MER 3001 (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 19 Jan 2018 New trial record